Oric Pharmaceuticals Inc — Cash Flow (NASDAQ:ORIC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -45.27 M-59.54 M-75.14 M-85.69 M-112.66 M-110.97 M -110.97 M Cash from investing activities -215.96 M158.44 M-109.25 M-43.4 M22.14 M-148.03 M -148.03 M Cash from financing activities 250.51 M49.13 M25.23 M85.66 M126.55 M245.26 M 245.26 M Free cash flow -45.94 M-60.48 M-77.22 M-86.54 M-113.85 M-111.68 M -111.68 M

News

ORIC Pharmaceuticals: Updates Did Not Bode Well For This Valuation (NASDAQ:ORIC)

Oric Pharma Misses The 'Best-In-Class' Boat Vs. Pfizer — And Plunges

ORIC Pharmaceuticals, Inc. (ORIC) Discusses Rinzimetostat Dose Optimization Data and Phase III Trial Design in Metastatic Prostate Cancer Transcript

JPMorgan reiterates Overweight on ORIC Pharmaceuticals stock

Cantor Fitzgerald reiterates Overweight on ORIC stock on efficacy

Avago, Lumentum among market cap stock movers on Monday

Oric Pharmaceuticals stock tumbles on Tazverik withdrawal

Jones Trading reiterates Buy on ORIC Pharmaceuticals stock

Wolfe Research reiterates Peerperform on ORIC stock after Ipsen withdrawal

After Golden Cross, Oric Pharmaceuticals, Inc. (ORIC)'s Technical Outlook is Bright

Wall Street Analysts Believe Oric Pharmaceuticals (ORIC) Could Rally 58.43%: Here's is How to Trade

H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress